Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimekizumab vs Adalimumab in Anterior Chest Wall Pain Associated With Active Axial Spondyloarthritis
NCT07836283Phase 3Not yet recruiting
- Sponsor
- Rouen University Hospital
- Start
- Oct 2026
- Primary completion
- Apr 2030
- Countries
- 1
01
Overview
A Phase 3 trial of bimekizumab in axial spondyloarthritis (axSpA), sponsored by Rouen University Hospital. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
bimekizumab
03
Conditions
axial spondyloarthritis (axSpA)
Beyond the preview
Go deeper on NCT07836283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07836283.